Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   PLS-a-GalCer: a novel targeted glycolipid therapy for solid tumors
  2. Burks, Julian; Tiwary, Shweta; Stevens, David M; Skoczen,Sarah; Kularatne,Ruvanthi Nilanga; Stern,Stephan; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2025, Mar 22; 13(3):
  1. 2.   Quantitation of Multiple Sphingolipid Classes Using Normal and Reversed-Phase LC-ESI-MS/MS: Comparative Profiling of Two Cell Lines
  2. Masood, M. A.; Rao, R. P.; Acharya, J. K.; Blonder, J.; Veenstra, T. D.
  3. Lipids. 2012, Feb; 47(2): 209-226.
  1. 3.   Ceramide Transfer Protein and Cancer
  2. Scheffer, L.; Raghavendra, P. R.; Ma, J. J.; Acharya, J. K.
  3. Anti-cancer agents in medicinal chemistry. 2011, Nov; 11(9): 904-910.
  1. 4.   Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1
  2. Borges, A. R.; Wieczorek, L.; Johnson, B.; Benesi, A. J.; Brown, B. K.; Kensinger, R. D.; Krebs, F. C.; Wigdahl, B.; Blumenthal, R.; Puri, A.; McCutchan, F. E.; Birx, D. L.; Polonis, V. R.; Schengrund, C. L.
  3. Virology. 2010, Dec; 408(1): 80-88.
  1. 5.   Quantitation of ceramide phosphorylethanolamines containing saturated and unsaturated sphingoid base cores
  2. Masood, M. A.; Yuan, C. Q.; Acharya, J. K.; Veenstra, T. D.; Blonder, J.
  3. Analytical Biochemistry. 2010, May 15; 400(2): 259-269.
  1. 6.   Application of tissue-specific NK and NKT cell activity for tumor immunotherapy
  2. Subleski, J. J.; Wiltrout, R. H.; Weiss, J. M.
  3. Journal of Autoimmunity. 2009, Nov-Dec; 33(3-4): 275-281.
  1. 7.   Ceramides: Branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency
  2. Kang, J. H.; Garg, H.; Sigano, D. M.; Francella, N.; Blumenthal, R.; Marquez, V. E.
  3. Bioorganic & Medicinal Chemistry. 2009 17(4): 1498-1505.
  1. 8.   Retroviruses Human Immunodeficiency Virus and Murine Leukemia Virus Are Enriched in Phosphoinositides
  2. Chan, R.; Uchil, P. D.; Jin, J.; Shui, G. H.; Ott, D. E.; Mothes, W.; Wenk, M. R.
  3. Journal of Virology. 2008 82(22): 11228-11238.
  1. 9.   Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities
  2. Duan, D.; Sigano, D. M.; Kelley, J. A.; Lai, C. C.; Lewin, N. E.; Kedei, N.; Peach, M. L.; Lee, J.; Abeyweera, T. P.; Rotenberg, S. A.; Kim, H.; Kim, Y. H.; El Kazzouli, S.; Chung, J. U.; Young, H. A.; Young, M. R.; Baker, A.; Colburn, N. H.
  3. Journal of Medicinal Chemistry. 2008 51(17): 5198-5220.
  1. 10.   Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry
  2. Garg, H.; Francella, N.; Tony, K. A.; Augustine, L. A.; Barchi, J. J.; Fantini, J.; Puri, A.; Mootoo, D. R.; Blumenthal, R.
  3. Antiviral Research. 2008 80(1): 54-61.
  1. 11.   Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion
  2. Finnegan, C. M.; Rawat, S. S.; Cho, E. H.; Guiffre, D. L.; Lockett, S.; Merrill, A. H.; Blumenthal, R.
  3. Journal of Virology. 2007, May; 81(10): 5294-5304.
  1. 12.   Fenretinide inhibits HIV infection by promoting viral endocytosis
  2. Finnegan, C. M.; Blumenthal, R.
  3. Antiviral Research. 2006, Feb; 69(2): 116-123.
  1. 13.   A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection
  2. Lund, N.; Branch, D. R.; Mylvaganam, M.; Chark, D.; Ma, X. Z.; Sakac, D.; Binnington, B.; Fantini, J.; Puri, Z.; Blumenthal, R.; Lingwood, C.
  3. Aids. 2006, Feb; 20(3): 333-343.
  1. 14.   Sphingolipids: Modulators of HIV-1 infection and pathogenesis
  2. Rawat, S. S.; Johnson, B. T.; Puri, A.
  3. Bioscience Reports. 2005, OCT; 25(5-6): 329-343.
  1. 15.   Ceramide, a target for antiretroviral therapy
  2. Finnegan, C. M.; Rawat, S. S.; Puri, A.; Wang, J. M.; Ruscetti, F. W.; Blumenthal, R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, OCT 26; 101(43): 15452-15457.
  1. 16.   Ceramidase regulates synaptic vesicle exocytosis and trafficking
  2. Rohrbough, J.; Rushton, E.; Palanker, L.; Woodruff, E.; Matthies, H. J. G.; Acharya, U.; Acharya, J. K.; Broadie, K.
  3. Journal of Neuroscience. 2004, SEP 8; 24(36): 7789-7803.
  1. 17.   Marine natural products and related compounds in clinical and advanced preclinical trials
  2. Newman, D. J.; Cragg, G. M.
  3. Journal of Natural Products. 2004, AUG; 67(8): 1216-1238.
  1. 18.   Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides
  2. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2004 172(2): 943-953.
  1. 19.   Dissociation of NKT stimulation, cytokine induction and NK activation in vivo by the use of distinct TcR-binding ceramides
  2. Winkler-Pickett, R. T.; Wiltrout, R. H.; Young, H. A.; Bere, E. W.; Murphy, W. E.; Ortaldo, J. R.
  3. Faseb Journal. 2004 18(5, Suppl. S): A1151-A1152.
  1. 20.   An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells
  2. Puri, A.; Rawat, S. S.; Lin, H. M. J.; Finnegan, C. A.; Mikovits, J.; Ruscetti, F. W.; Blumenthal, R.
  3. Aids. 2004 18(6): 849-858.
  1. 21.   Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion
  2. Rawat, S. S.; Eaton, J.; Gallo, S. A.; Martin, T. D.; Ablan, S.; Ratnayake, S.; Viard, M.; KewalRamani, V. N.; Wang, J. M.; Blumenthal, R.; Puri, A.
  3. Virology. 2004 318(1): 55-65.
  1. 22.   Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis
  2. Smyth, M. J.; Cretney, E.; Takeda, K.; Wiltrout, R. H.; Sedger, L. M.; Kayagaki, N.; Yagita, H.; Okumura, K.
  3. Journal of Experimental Medicine. 2001 193(6): 661-670.
  1. 23.   Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5
  2. Hug, P.; Lin, H. M. J.; Korte, T.; Xiao, X. D.; Dimitrov, D. S.; Wang, J. M.; Puri, A.; Blumenthal, R.
  3. Journal of Virology. 2000 74(14): 6377-6385.
  1. 24.   Selective accumulation of the endoplasmic reticulum-Golgi intermediate compartment induced by the antitumor drug KRN5500
  2. Kamishohara, M.; Kenney, S.; Domergue, R.; Vistica, D. T.; Sausville, E. A.
  3. Experimental Cell Research. 2000 256(2): 468-479.
  1. 25.   Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells
  2. Davis, M. A.; Flaws, J. A.; Young, M.; Collins, K.; Colburn, N. H.
  3. Toxicological Sciences. 2000 53(1): 48-55.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel